Cargando…

Machine Learning-Augmented Propensity Score Analysis of Percutaneous Coronary Intervention in Over 30 Million Cancer and Non-cancer Patients

Background: It is unknown to what extent the clinical benefits of PCI outweigh the risks and costs in patients with vs. without cancer and within each cancer type. We performed the first known nationally representative propensity score analysis of PCI mortality and cost among all eligible adult inpa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monlezun, Dominique J., Lawless, Sean, Palaskas, Nicolas, Peerbhai, Shareez, Charitakis, Konstantinos, Marmagkiolis, Konstantinos, Lopez-Mattei, Juan, Mamas, Mamas, Iliescu, Cezar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055825/ https://www.ncbi.nlm.nih.gov/pubmed/33889598 http://dx.doi.org/10.3389/fcvm.2021.620857

Ejemplares similares

TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients
por: Monlezun, Dominique J., et al.
Publicado: (2021)

Percutaneous Coronary Intervention in Patients With Gynecological Cancer: Machine Learning-Augmented Propensity Score Mortality and Cost Analysis for 383,760 Patients
por: Thomason, Nicole, et al.
Publicado: (2022)

Stress cardiomyopathy in hospitalized patients with cancer: machine learning analysis by primary malignancy type
por: Javaid, Awad I., et al.
Publicado: (2021)

Fractional Flow Reserve Cardio-Oncology Effects on Inpatient Mortality, Length of Stay, and Cost Based on Malignancy Type: Machine Learning Supported Nationally Representative Case-Control Study of 30 Million Hospitalizations
por: Chauhan, Siddharth, et al.
Publicado: (2022)

COVID-19 COMPLICATED BY RESPIRATORY FAILURE INCREASES INPATIENT STEMI MORTALITY: MACHINE LEARNING-AUGMENTED MODIFIED PROPENSITY SCORE ADJUSTED LONGITUDINAL COHORT STUDY
por: Ynalvez, Leslie Ammabel, et al.
Publicado: (2023)

TAVR in Cancer Patients: Comprehensive Review, Meta-Analysis, and Meta-Regression
por: Marmagkiolis, Konstantinos, et al.
Publicado: (2021)

Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
por: Ahmed, Talha, et al.
Publicado: (2022)

Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the “forgotten pulmonic valve”
por: Monlezun, Dominique J., et al.
Publicado: (2023)

How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience
por: Jacob, Robin, et al.
Publicado: (2021)

Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy
por: Jacob, Robin, et al.
Publicado: (2020)

Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography
por: Agha, Ali M., et al.
Publicado: (2020)

Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention
por: Bashar, Hussein, et al.
Publicado: (2022)

Artificial Intelligence-Augmented Propensity Score, Cost Effectiveness and Computational Ethical Analysis of Cardiac Arrest and Active Cancer with Novel Mortality Predictive Score
por: Monlezun, Dominique J., et al.
Publicado: (2022)

Coronary Revascularization in Patients With Cancer
por: Pushparaji, Bala, et al.
Publicado: (2023)

Percutaneous Muscular Ventricular Septal Defect Closure with 2D Transthoracic Echocardiography: Can We Sufficiently Visualize It?
por: Mutlu, Deniz, et al.
Publicado: (2021)

Prognostic Factors and Overall Survival After Pericardiocentesis in Patients With Cancer and Thrombocytopenia
por: Wilson, Nathaniel R., et al.
Publicado: (2021)

Reclassification of Treatment Strategy with Fractional Flow Reserve in Cancer Patients with Coronary Artery Disease
por: Kim, Jin Wan, et al.
Publicado: (2022)

Percutaneous Coronary Angioplasty in Patients with Cancer: Clinical Challenges and Management Strategies
por: Doolub, Gemina, et al.
Publicado: (2022)

Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field
por: Liu, Victor Y., et al.
Publicado: (2018)

Skip Soft Definitions and Focus on Hard Endpoints
por: Lopez-Mattei, Juan C., et al.
Publicado: (2019)

Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis
por: Ahmed, Talha, et al.
Publicado: (2022)

An Unusual Endovascular Therapeutic Approach for a Rare Case of May-Thurner Syndrome
por: DaSilva-DeAbreu, Adrian, et al.
Publicado: (2017)

Percutaneous coronary intervention and 30‐day unplanned readmission with chest pain in the United States (Nationwide Readmissions Database)
por: Sykes, RobertA., et al.
Publicado: (2021)

Hyperkalemia masked by pseudo-stemi infarct pattern and cardiac arrest
por: Peerbhai, Shareez, et al.
Publicado: (2017)

2021. The year in review. Structural heart interventions
por: Marmagkiolis, Konstantinos, et al.
Publicado: (2022)

TRENDS OF IN-HOSPITAL AND 30-DAY MORTALITY AFTER PERCUTANEOUS CORONARY INTERVENTION IN ENGLAND BEFORE AND AFTER THE COVID-19 ERA
por: Mohamed, Mohamed, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
por: Palaskas, Nicolas, et al.
Publicado: (2020)

Persistent sex disparities in clinical outcomes with percutaneous coronary intervention: Insights from 6.6 million PCI procedures in the United States
por: Potts, Jessica, et al.
Publicado: (2018)

Percutaneous Coronary Intervention Mortality, Cost, Complications, and Disparities after Radiation Therapy: Artificial Intelligence-Augmented, Cost Effectiveness, and Computational Ethical Analysis
por: Monlezun, Dominique J.
Publicado: (2023)

Trigger related outcomes of takotsubo syndrome in a cancer population
por: Safdar, Ayesha, et al.
Publicado: (2022)

A contemporary risk model for predicting 30-day mortality following percutaneous coronary intervention in England and Wales
por: McAllister, Katherine S.L., et al.
Publicado: (2016)

Quantitative Flow Ratio and Virtual Percutaneous Coronary Intervention for Serial Coronary Stenoses: Attractive Technology, But Still Crawling
por: Sumaya, Wael, et al.
Publicado: (2022)

Complex, high‐risk percutaneous coronary intervention types, trends, and in‐hospital outcomes among different age groups: An insight from a national registry
por: Shamkhani, Warkaa, et al.
Publicado: (2022)

QT Prolongation in Cancer Patients
por: Kim, Peter, et al.
Publicado: (2021)

Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management
por: Zarifa, Abdulrazzak, et al.
Publicado: (2021)

Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3·4 million individuals
por: Wu, Jianhua, et al.
Publicado: (2022)

How Common Is Pre-Existing Cardiovascular Disease in Cancer Patients: What Do We Know? Does It Matter?
por: Mamas, Mamas A., et al.
Publicado: (2022)

Temporal trends in relative survival following percutaneous coronary intervention
por: Hulme, William J, et al.
Publicado: (2019)

Racial and Socioeconomic Disparities in Out-Of-Hospital Cardiac Arrest Outcomes: Artificial Intelligence-Augmented Propensity Score and Geospatial Cohort Analysis of 3,952 Patients
por: Monlezun, Dominique J., et al.
Publicado: (2021)

Place and Underlying Cause of Death During the COVID-19 Pandemic: Retrospective Cohort Study of 3.5 Million Deaths in England and Wales, 2014 to 2020
por: Wu, Jianhua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q051qcae2id64k2hn3jba30cuv